The Pain Outcomes Comparing Yoga vs. Structured Exercise (POYSE) Trial in Veterans With Fibromyalgia: Study Design and Methods

Vivianne L Allsop, Arlene A Schmid, Kristine K Miller, James E Slaven, Joanne K Daggy, Amanda Froman, Matthew Kline, Christy Sargent, Dustin D French, Dennis Ang, Marieke Van Puymbroeck, Nancy L Schalk, Matthew J Bair, Vivianne L Allsop, Arlene A Schmid, Kristine K Miller, James E Slaven, Joanne K Daggy, Amanda Froman, Matthew Kline, Christy Sargent, Dustin D French, Dennis Ang, Marieke Van Puymbroeck, Nancy L Schalk, Matthew J Bair

Abstract

Background: Fibromyalgia is a common pain condition that often leads to significant disability. Unfortunately, the effectiveness of most medications for fibromyalgia is limited, and there is a need for alternative, non-pharmacological therapies. Yoga and aerobic exercise are both evidence-based non-pharmacological treatments for fibromyalgia. However, no prior studies have directly compared the effectiveness of yoga vs. exercise.

Objective: This article describes the study design and recruitment outcomes of the Pain Outcomes comparing Yoga vs. Structured Exercise (POYSE) Trial, a two-arm randomized comparative effectiveness trial.

Methods: Veterans with fibromyalgia, defined by the 2010 American College of Rheumatology diagnostic criteria, who also experienced at least moderate pain severity were enrolled. The participants were randomized to a 12-week yoga-based or a structured exercise program (SEP) and will undergo comprehensive outcome assessments at baseline, 1, 3, 6, and 9 months by interviewers blinded to treatment assignment. The primary outcome will be the overall severity of fibromyalgia as measured by the total Fibromyalgia Impact Questionnaire-Revised. Secondary outcomes included depression, anxiety, health-related quality of life, pain beliefs, fatigue, sleep, and self-efficacy.

Results: A total of 2,671 recruitment letters were sent to potential participants with fibromyalgia. Of the potential participants, 623 (23.3%) were able to be contacted by telephone and had their eligibility assessed. Three hundred seventy-one of those interviewed were found to be eligible (59.6%) and 256 (69.0%) agreed to participate and were randomized to the YOGA (n = 129) or the SEP (n = 127) arm of the trial.

Conclusions: Clinicians are faced with numerous challenges in treating patients with fibromyalgia. The interventions being tested in the POYSE trial have the potential to provide primary care and other care settings with new treatment options for clinicians while simultaneously providing a much needed relief for patients suffering from fibromyalgia.

Trial registration: Funded by VA Rehabilitation Research and Development (D1100-R); Trial registration: ClinicalTrials.gov, NCT01797263.

Keywords: comparative effectiveness; exercise; fibromyalgia; randomized clinical trial; veterans; yoga.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Allsop, Schmid, Miller, Slaven, Daggy, Froman, Kline, Sargent, French, Ang, Van Puymbroeck, Schalk and Bair.

Figures

Figure 1
Figure 1
Overall study design.
Figure 2
Figure 2
Recruitment outcomes.

References

    1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. (1995) 38:19–28. 10.1002/art.1780380104
    1. Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. . Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res. (2013) 65:786–92. 10.1002/acr.21896
    1. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. . Work and disability status of persons with fibromyalgia. J Rheumatol. (1997) 24:1171–8.
    1. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. (2003) 30:1318–25.
    1. Eisen SA, Kang HK, Murphy FM, Blanchard MS, Reda DJ, Henderson WG, et al. . Gulf War veterans' health: medical evaluation of a US cohort. Ann Intern Med. (2005) 142:881–90. 10.7326/0003-4819-142-11-200506070-00005
    1. National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.). & National Institutes of Health (U.S.) . Questions & Answers About–Fibromyalgia. Bethesda, MD: National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health, Public Health Service; (2004).
    1. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. . A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. (2004) 50:2974–84. 10.1002/art.20485
    1. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. . Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. (2005) 52:1264–73. 10.1002/art.20983
    1. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. (2005) 52:2495–505. 10.1002/art.21191
    1. Andrade A, Dominski FH, Sieczkowska SM. What we already know about the effects of exercise in patients with fibromyalgia: an umbrella review. Semin Arthritis Rheum. (2020) 50:1465–80. 10.1016/j.semarthrit.2020.02.003
    1. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. (2004) 292:2388–95. 10.1001/jama.292.19.2388
    1. Busch AJ, Webber SC, Brachaniec M, Bidonde J, Bello-Haas VD, Danyliw AD, et al. . Exercise therapy for fibromyalgia. Curr Pain Headache Rep. (2011) 15:358–67. 10.1007/s11916-011-0214-2
    1. Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ, et al. . A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med. (1999) 21:180–91. 10.1007/BF02908299
    1. Andrade A, de Azevedo Klumb Steffens R, Sieczkowska SM, PeyréTartaruga LA, Torres Vilarino G. A systematic review of the effects of strength training in patients with fibromyalgia: clinical outcomes and design considerations. Adv Rheumatol. (2018) 58:36. 10.1186/s42358-018-0033-9
    1. Chong CS, Tsunaka M, Tsang HW, Chan EP, Cheung WM. Effects of yoga on stress management in healthy adults: a systematic review. Altern Ther Health Med. (2011) 17:32–8.
    1. Carson JW, Carson KM, Jones KD, Bennett RM, Wright CL, Mist SD, et al. . A pilot randomized controlled trial of the yoga of awareness program in the management of fibromyalgia. Pain. (2010) 151:530–9. 10.1016/j.pain.2010.08.020
    1. Curtis K, Osadchuk A, Katz J. An 8-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia. J Pain Res. (2011) 4:189–201. 10.2147/JPR.S22761
    1. da Silva GD, Lorenzi-Filho G, Lage LV. Effects of yoga and the addition of Tui Na in patients with fibromyalgia. J Altern Complement Med. (2007) 13:1107–13. 10.1089/acm.2007.0615
    1. Sieczkowska SM, Casagrande PO, Coimbra DR, Vilarino GT, Andreato LV, Andrade A. Effect of yoga on the quality of life of patients with rheumatic diseases: systematic review with meta-analysis. Complement Ther Med. (2019) 46:9–18. 10.1016/j.ctim.2019.07.006
    1. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. (2009) 11:R120. 10.1186/ar2783
    1. Hanson R, Gerber K. Models of pain. In: Turk D. editor. Coping with Chronic Pain: A Guide to Patient Self-Management. New York, NY: Guilford Press; (1990). p. 15–44.
    1. Gallagher RM. The pain medicine and primary care community rehabilitation model: monitored care for pain disorders in multiple settings. Clin J Pain. (1999) 15:1–3. 10.1097/00002508-199903000-00001
    1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. . The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (2010) 62:600–10. 10.1002/acr.20140
    1. Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. (2002) 40:771–81. 10.1097/00005650-200209000-00007
    1. Schmid AA, Van Puymbroeck M, Koceja DM. Effect of a 12-week yoga intervention on fear of falling and balance in older adults: a pilot study. Arch Phys Med Rehabil. (2010) 91:576–83. 10.1016/j.apmr.2009.12.018
    1. Sherman KJ. Guidelines for developing yoga interventions for randomized trials. Evid Based Complement Alternat Med. (2012) 2012:143271. 10.1155/2012/143271
    1. Jones KD, Clark SR. Individualizing the exercise prescription for persons with fibromyalgia. Rheum Dis Clin North Am. (2002) 28:419–36. 10.1016/S0889-857X(01)00010-2
    1. Staud R. Autonomic dysfunction in fibromyalgia syndrome: postural orthostatic tachycardia. Curr Rheumatol Rep. (2008) 10:463–6. 10.1007/s11926-008-0076-8
    1. Jones KD, Adams D, Winters-Stone K, Burckhardt CS. A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988–2005). Health Qual Life Outcomes. (2006) 4:67. 10.1186/1477-7525-4-67
    1. da Cunha Ribeiro RP, Franco TC, Pinto AJ, Pontes Filho MAG, Domiciano DS, de Sá Pinto AL, et al. . Prescribed vs. preferred intensity resistance exercise in fibromyalgia pain. Front Physiol. (2018) 10:1097. 10.3389/fphys.2018.01097
    1. Meiworm L, Jakob E, Walker UA, Peter HH, Keul J. Patients with fibromyalgia benefit from aerobic endurance exercise. Clin Rheumatol. (2000) 19:253–7. 10.1007/s100670070040
    1. King SJ, Wessel J, Bhambhani Y, Sholter D, Maksymowych W. The effects of exercise and education, individually or combined, in women with fibromyalgia. J Rheumatol. (2002) 29:2620–7.
    1. Richards SC, Scott DL. Prescribed exercise in people with fibromyalgia: parallel group randomized controlled trial. BMJ. (2002) 325:185. 10.1136/bmj.325.7357.185
    1. Fulcher KY, White PD. Randomized controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. (1997) 314:1647–52. 10.1136/bmj.314.7095.1647
    1. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. (1970) 2:92–8.
    1. Mengshoel AM, Vøllestad NK, Førre O. Pain and fatigue induced by exercise in fibromyalgia patients and sedentary healthy subjects. Clin Exp Rheumatol. (1995) 13:477–82.
    1. Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum. (1998) 41:406–13. 10.1002/1529-0131(199803)41:3<406
    1. Jubrias SA, Bennett RM, Klug GA. Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum. (1994) 37:801–7. 10.1002/art.1780370604
    1. Olsen NJ, Park JH. Skeletal muscle abnormalities in patients with fibromyalgia. Am J Med Sci. (1998) 315:351–8. 10.1097/00000441-199806000-00003
    1. Weigent DA, Bradley LA, Blalock JE, Alarcón GS. Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia. Am J Med Sci. (1998) 315:405–12. 10.1097/00000441-199806000-00009
    1. Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc. (1999) 74:385–98. 10.4065/74.4.385
    1. Staud R, Robinson ME, Price DD. Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain. (2005) 118:176–84. 10.1016/j.pain.2005.08.007
    1. Vierck CJ Jr, Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD. The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain. (2001) 2:334–44. 10.1054/jpai.2001.25533
    1. Mease PJ, Clauw DJ, Christensen R, Crofford LJ, Gendreau RM, Martin SA, et al. . Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol. (2011) 38:1487–95. 10.3899/jrheum.110277
    1. Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, et al. . Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA. (2009) 301:2099–110. 10.1001/jama.2009.723
    1. Kroenke K, Bair M, Damush T, Hoke S, Nicholas G, Kempf C, et al. . Stepped care for affective disorders and musculoskeletal pain (SCAMP) study: design and practical implications of an intervention for comorbid pain and depression. Gen Hosp Psychiatry. (2007) 29:506–17. 10.1016/j.genhosppsych.2007.08.005
    1. Bennett R. The fibromyalgia impact questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. (2005) 23(5 Suppl 39):S154–62.
    1. Friend R, Bennett RM. Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: an analysis of the revised fibromyalgia impact questionnaire (FIQR) and its variant, the symptom impact questionnaire (SIQR), along with pain locations. Arthritis Res Ther. (2011) 13:R58. 10.1186/ar3311
    1. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, et al. . Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. (2009) 36:2318–29. 10.3899/jrheum.090367
    1. Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. (1994) 23:129–38.
    1. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the brief pain inventory for chronic non-malignant pain. J Pain. (2004) 5:133–7. 10.1016/j.jpain.2003.12.005
    1. Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. (1995) 7:524–32. 10.1037/1040-3590.7.4.524
    1. Nicolaidis C, Chianello T, Gerrity M. Development and preliminary psychometric testing of the centrality of pain scale. Pain Med. (2011) 12:612–7. 10.1111/j.1526-4637.2011.01072.x
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. (2001) 16:606–13. 10.1046/j.1525-1497.2001.016009606.x
    1. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. (2006) 166:1092–7. 10.1001/archinte.166.10.1092
    1. Ouimette P, Wade M, Prins A, Schohn M. Identifying PTSD in primary care: comparison of the primary care-PTSD screen (PC-PTSD) and the general health questionnaire-12 (GHQ). J Anxiety Disord. (2008) 22:337–43. 10.1016/j.janxdis.2007.02.010
    1. Weathers F, Ford J. “Psychometric review of PTSD checklist (PCL-C, PCL-S, PCL-M, PCL-PR).” In: Stamm BH. editor. Measurement of Stress, Trauma, and Adaptation. Lutherville, MD: Sidran Press; (1996). p. 250–2.
    1. Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. (1995) 39:315–25. 10.1016/0022-3999(94)00125-O
    1. Lin JM, Brimmer DJ, Maloney EM, Nyarko E, Belue R, Reeves WC. Further validation of the multidimensional fatigue inventory in a US adult population sample. Popul Health Metr. (2009) 7:18. 10.1186/1478-7954-7-18
    1. Allen RP, Kosinski M, Hill-Zabala CE, Calloway MO. Psychometric evaluation and tests of validity of the medical outcomes study 12-item sleep scale (MOS sleep). Sleep Med. (2009) 10:531–9. 10.1016/j.sleep.2008.06.003
    1. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. (1996) 34:220–33. 10.1097/00005650-199603000-00003
    1. Powell LE, Myers AM. The activities-specific balance confidence (ABC) scale. J Gerontol A Biol Sci Med Sci. (1995) 50A:M28–34. 10.1093/gerona/50A.1.M28
    1. Schumann A, Hapke U, Meyer C, Rumpf HJ, John U. Measuring sense of coherence with only three items: a useful tool for population surveys. Br J Health Psychol. (2003) 8(Pt 4):409–21. 10.1348/135910703770238275
    1. Chetta A, Zanini A, Pisi G, Aiello M, Tzani P, Neri M, et al. . Reference values for the 6-min walk test in healthy subjects 20-50 years old. Respir Med. (2006) 100:1573–8. 10.1016/j.rmed.2006.01.001
    1. Peters DM, Fritz SL, Krotish DE. Assessing the reliability and validity of a shorter walk test compared with the 10-meter walk test for measurements of gait speed in healthy, older adults. J Geriatr Phys Ther. (2013) 36:24–30. 10.1519/JPT.0b013e318248e20d
    1. Jones CJ, Rikli RE, Max J, Noffal G. The reliability and validity of a chair sit-and-reach test as a measure of hamstring flexibility in older adults. Res Q Exerc Sport. (1998) 69:338–43. 10.1080/02701367.1998.10607708
    1. Hesseberg K, Bentzen H, Bergland A. Reliability of the senior fitness test in community-dwelling older people with cognitive impairment. Physiother Res Int. (2015) 20:37–44. 10.1002/pri.1594
    1. Agarwal S, Kiely PD. Two simple, reliable and valid tests of proximal muscle function, and their application to the management of idiopathic inflammatory myositis. Rheumatology. (2006) 45:874–9. 10.1093/rheumatology/kel017
    1. Rose DJ, Lucchese N, Wiersma LD. Development of a multidimensional balance scale for use with functionally independent older adults. Arch Phys Med Rehabil. (2006) 87:1478–85. 10.1016/j.apmr.2006.07.263
    1. Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. (2001) 4:256–62.
    1. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. (1989) 10:407–15. 10.1016/0197-2456(89)90005-6
    1. Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H. Capturing the patient's view of change as a clinical outcome measure. JAMA. (1999) 282:1157–62. 10.1001/jama.282.12.1157
    1. Jones SM, Lange J, Turner J, Cherkin D, Ritenbaugh C, Hsu C, et al. . Development and validation of the EXPECT questionnaire: assessing patient expectations of outcomes of complementary and alternative medicine treatments for chronic pain. J Altern Complement Med. (2016) 22:936–46. 10.1089/acm.2016.0242
    1. Toussaint A, Murray AM, Voigt K, Herzog A, Gierk B, Kroenke K, et al. . Development and validation of the somatic symptom disorder-B criteria scale (SSD-12). Psychosom Med. (2016) 78:5–12. 10.1097/PSY.0000000000000240
    1. Gierk B, Kohlmann S, Kroenke K, Spangenberg L, Zenger M, Brähler E, et al. . The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med. (2014) 174:399–407. 10.1001/jamainternmed.2013.12179
    1. Liang K-Y, Zeger SL. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhya: Indian J Stat. (2000) 62:134–48.
    1. Lu K. On efficiency of constrained longitudinal data analysis vs. longitudinal analysis of covariance. Biometrics. (2010) 66:891–6. 10.1111/j.1541-0420.2009.01332.x
    1. Liu GF, Lu K, Mogg R, Mallick M, Mehrotra DV. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med. (2009) 28:2509–30. 10.1002/sim.3639
    1. Lupi JB, Carvalho de Abreu DC, Ferreira MC, Oliveira RDR, Chaves TC. Brazilian Portuguese version of the revised fibromyalgia impact questionnaire (FIQR-Br): cross-cultural validation, reliability, and construct and structural validation. Disabil Rehabil. (2017) 39:1650–63. 10.1080/09638288.2016.1207106
    1. Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. . Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices–budget impact analysis. Value Health. (2007) 10:336–47. 10.1111/j.1524-4733.2007.00187.x
    1. Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, et al. . Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. (2014) 17:5–14. 10.1016/j.jval.2013.08.2291
    1. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; (1996).
    1. Center for Innovation Engagement (CIE) . Cost-calculator 508. Available online at: (accessed April 30, 2022).
    1. Center for Innovation and Engagement . Cost Calculator. Available online at: (accessed April 30, 2022).
    1. Center for Innovation Engagement . Cost Calculator Guide. Available online at: (accessed April 30, 2022).
    1. Bravo C, Skjaerven LH, Guitard Sein-Echaluce L, Catalan-Matamoros D. Effectiveness of movement and body awareness therapies in patients with fibromyalgia: a systematic review and meta-analysis. Eur J Phys Rehabil Med. (2019) 55:646–57. 10.23736/S1973-9087.19.05291-2
    1. Langhorst J, Klose P, Dobos GJ, Bernardy K, Häuser W. Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Rheumatol Int. (2013) 33:193–207. 10.1007/s00296-012-2360-1
    1. Mist SD, Firestone KA, Jones KD. Complementary and alternative exercise for fibromyalgia: a meta-analysis. J Pain Res. (2013) 6:247–60. 10.2147/JPR.S32297
    1. Lazaridou A, Koulouris A, Devine JK, Haack M, Jamison RN, Edwards RR, et al. . Impact of daily yoga-based exercise on pain, catastrophizing, and sleep amongst individuals with fibromyalgia. J Pain Res. (2019) 12:2915–23. 10.2147/JPR.S210653
    1. Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. (2009) 151:203–5. 10.7326/0003-4819-151-3-200908040-00125
    1. Lacefield K, Samph SP, Orbon S, Otis J. Integrated intervention for comorbid post-traumatic stress disorder and fibromyalgia: a pilot study of women veterans. Psychol Trauma. (2020) 12:725–9. 10.1037/tra0000635
    1. Mohanty AF, Helmer DA, Muthukutty A, McAndrew LM, Carter ME, Judd J, et al. . Fibromyalgia syndrome care of Iraq-and Afghanistan-deployed veterans in Veterans Health Administration. J Rehabil Res Dev. (2016) 53:45–58. 10.1682/JRRD.2014.10.0265

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj